Kellogg Huber Hansen Todd Evans Figel PLLC

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases136

Challenger50%

Patent Owner50%

NPE50%

kellogghansen

kellogghansen.com

Practice Areas

Comp. Arch. and SoftwareCommunicationsBiotech

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
12/12/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. [426] , [427] , [438] . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. [429] , [431] . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024) ORDER. For good cause, the following motions to withdraw are GRANTED: ECF Nos. [426] , [427] , [438] . The Clerk SHALL terminate Jennifer Brooks Crozier, Rocco Recce, Anish R. Desai, Kathryn Leicht, Kellie Van Beck, Matthew D. Sieger, Natalie C. Kennedy, Tom Yu, and Zhen Lin as counsel of record in this matter. Additionally, for good cause, the following motions to seal are GRANTED: ECF Nos. [429] , [431] . Signed by Chief District Judge Thomas S. Kleeh on 12/12/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 12/12/2024)
12/12/24	Regeneron Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc 1:22-CV-00061 ( N.D. WV )	MOTION to Withdraw as Attorney ANISH R. DESAI, KATHRYN LEICHT, KELLIE VAN BECK, MATTHEW D. SEIGER, NATALIE C. KENNEDY, TOM YU, AND ZHEN LIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 12/12/2024)
10/31/24	Regeneron Pharmaceuticals, Inc. v. Formycon AG 1:23-CV-00097 ( N.D. WV )	ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 378 ). Ms. Anderson shall be TERMINATED as counsel of record in this matter. Signed by Chief District Judge Thomas S. Kleeh on 10/31/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 10/31/2024)
10/21/24	Regeneron Pharmaceuticals Inc v. Celltrion Inc 1:24-CV-00053 ( N.D. WV )	ORDER STIPULATION AND ORDER. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00053-TSK (snc) (Entered: 10/21/2024)
10/21/24	Regeneron Pharmaceuticals Inc v. Samsung Bioepis Co Ltd 1:23-CV-00094 ( N.D. WV )	STIPULATION AND ORDER REGARDING CASE MANAGEMENT. Signed by Chief District Judge Thomas S. Kleeh on 10/21/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM, 1:23-cv-00094-TSK-JPM, 1:23-cv-00097-TSK-JPM, 1:23-cv-00106-TSK-JPM (snc) (Entered: 10/21/2024)
09/13/24	Regeneron Pharmaceuticals Inc v. Sandoz Inc 2:24-CV-08760 ( D. NJ )	Order of MDL Panel transferring case to the Northern District of West Virginia. (krg, ) (Entered: 09/13/2024)
09/13/24	Regeneron Pharmaceuticals Inc v. Sandoz Inc 2:24-CV-08760 ( D. NJ )	Case extracted via ECF to the Northern District of West Virginia. (krg, ) (Entered: 09/13/2024)
09/13/24	Regeneron Pharmaceuticals Inc v. Sandoz Inc 2:24-CV-08760 ( D. NJ )	Case transferred from New Jersey has been opened in Northern District of West Virginia as case 1:24-cv-00085, filed 09/13/2024. (jal, ) (Entered: 09/13/2024)
08/26/24	Regeneron Pharmaceuticals Inc v. Sandoz Inc 3:24-CV-08760 ( D. NJ )	COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15616581) , Related Case Selected, filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 Part 1, # 16 Exhibit 15 Part 2, # 17 Exhibit 16, # 18 Exhibit 17 Part 1, # 19 Exhibit 17 Part 2, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Civil Cover Sheet)(MILLER, KEITH) (Entered: 08/26/2024) COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15616581) , Related Case Selected, filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 Part 1, # 16 Exhibit 15 Part 2, # 17 Exhibit 16, # 18 Exhibit 17 Part 1, # 19 Exhibit 17 Part 2, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Civil Cover Sheet)(MILLER, KEITH) (Entered: 08/26/2024)
08/26/24	Regeneron Pharmaceuticals Inc v. Sandoz Inc 3:24-CV-08760 ( D. NJ )	COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15616581), Related Case Selected, filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 Part 1, # 16 Exhibit 15 Part 2, # 17 Exhibit 16, # 18 Exhibit 17 Part 1, # 19 Exhibit 17 Part 2, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Civil Cover Sheet)(MILLER, KEITH) (Entered: 08/26/2024) COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15616581), Related Case Selected, filed by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15 Part 1, # 16 Exhibit 15 Part 2, # 17 Exhibit 16, # 18 Exhibit 17 Part 1, # 19 Exhibit 17 Part 2, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Civil Cover Sheet)(MILLER, KEITH) (Entered: 08/26/2024)